| Treatment options: Natural or lifestyle changes |
|
Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion 1992; 51 Suppl 1:30-4. |
|
Garnett WR. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. American Journal Of Hospital Pharmacy 1993; 50(4 Suppl 1):S11-8. |
|
Katz PO. Gastroesophageal reflux disease. Journal Of The American Geriatrics Society 1998; 46(12):1558-65. |
|
Kikendall JW. Pill esophagitis. Journal Of Clinical Gastroenterology 1999; 28(4):298-305. |
|
Kitchin LI, Castell DO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease [see comments]. Archives Of Internal Medicine 1991; 151(3):448-54. |
|
Lanas A, Hirschowitz BI. Significant role of aspirin use in patients with esophagitis. Journal Of Clinical Gastroenterology 1991; 13(6):622-7. |
|
Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterology Clinics Of North America 1996; 25(2):373-96. |
